Cargando…
Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier B. V
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227515/ https://www.ncbi.nlm.nih.gov/pubmed/32480327 http://dx.doi.org/10.1016/j.msard.2020.102201 |
| _version_ | 1783534512356982784 |
|---|---|
| author | Suwanwongse, Kulachanya Shabarek, Nehad |
| author_facet | Suwanwongse, Kulachanya Shabarek, Nehad |
| author_sort | Suwanwongse, Kulachanya |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7227515 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Elsevier B. V |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-72275152020-05-18 Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab Suwanwongse, Kulachanya Shabarek, Nehad Mult Scler Relat Disord Correspondence Elsevier B. V 2020-07 2020-05-15 /pmc/articles/PMC7227515/ /pubmed/32480327 http://dx.doi.org/10.1016/j.msard.2020.102201 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Suwanwongse, Kulachanya Shabarek, Nehad Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title | Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title_full | Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title_fullStr | Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title_full_unstemmed | Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title_short | Benign course of COVID-19 in a multiple sclerosis patient treated with Ocrelizumab |
| title_sort | benign course of covid-19 in a multiple sclerosis patient treated with ocrelizumab |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7227515/ https://www.ncbi.nlm.nih.gov/pubmed/32480327 http://dx.doi.org/10.1016/j.msard.2020.102201 |
| work_keys_str_mv | AT suwanwongsekulachanya benigncourseofcovid19inamultiplesclerosispatienttreatedwithocrelizumab AT shabareknehad benigncourseofcovid19inamultiplesclerosispatienttreatedwithocrelizumab |